NA - Isle of Man, Middle, Isle of Man Juvenescence is the famous Corporate Investor, which was founded in 2016. The company was established in Europe in Isle of Man. The main department of described Corporate Investor is located in the Douglas.
This organization was formed by Declan Doogan, Greg Bailey, Jim Mellon.
The top amount of exits for fund were in 2018. Comparing to the other companies, this Juvenescence performs on 19 percentage points less the average number of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this Corporate Investor is 10 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Juvenescence, startups are often financed by Jim Mellon, KIZOO, John Mauldin. The meaningful sponsors for the fund in investment in the same round are WuXi AppTec, Pavilion Capital, Longevity Vision Fund. In the next rounds fund is usually obtained by Longevity Vision Fund, Sinovation Ventures, Qiming Venture Partners.
Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Genetics, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Insilico Medicine, AgeX Therapeutics, BHB Therapeutics.
Related Funds
| Fund Name | Location |
| Beststudy | China, Guangdong, Guangzhou |
| China Telcom | Beijing, Beijing, China |
| FutuRx | HaMerkaz, Israel, Ness Ziona |
| GOODWILL Ventures | Levittown, New York, United States |
| Green Park & Golf Ventures | Dallas, Texas, United States |
| Infosys Foundation | California, Palo Alto, United States |
| Innosight Ventures | Central Region, Singapore, Singapore |
| Jumbofund | - |
| Qi An Xin | Beijing, Beijing, China |
| Telenor | Akershus, Fornebu, Norway |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Morphoceuticals | $8M | 23 Jan 2023 | Marblehead, Massachusetts, United States | ||
MDI Therapeutics | $9M | 21 Mar 2022 | Novi, Michigan, United States | ||
LyGenesis | $11M | 30 Dec 2020 | Pittsburgh, Pennsylvania, United States | ||
LyGenesis | $4M | 21 Oct 2019 | Pittsburgh, Pennsylvania, United States | ||
Souvien Therapeutics | $3M | 28 May 2019 | Salt Lake City, Utah, United States | ||
BYOMass | $1M | 27 Mar 2019 | Massachusetts, United States | ||
BHB Therapeutics | $3M | 04 Feb 2019 | NA - Isle of Man, Middle, Isle of Man | ||
AgeX Therapeutics | $43M | 04 Sep 2018 | California, United States | ||
Napa Therapeutics | $3M | 06 Aug 2018 | Los Angeles, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Morphoceuticals | $8M | 23 Jan 2023 | Marblehead, Massachusetts, United States | ||
MDI Therapeutics | $9M | 21 Mar 2022 | Novi, Michigan, United States | ||
LyGenesis | $11M | 30 Dec 2020 | Pittsburgh, Pennsylvania, United States | ||
LyGenesis | $4M | 21 Oct 2019 | Pittsburgh, Pennsylvania, United States | ||
Souvien Therapeutics | $3M | 28 May 2019 | Salt Lake City, Utah, United States | ||
BYOMass | $1M | 27 Mar 2019 | Massachusetts, United States | ||
BHB Therapeutics | $3M | 04 Feb 2019 | NA - Isle of Man, Middle, Isle of Man | ||
AgeX Therapeutics | $43M | 04 Sep 2018 | California, United States | ||
Napa Therapeutics | $3M | 06 Aug 2018 | Los Angeles, California, United States |
Get matched with relevant funds
